Genetic Technologies Ltd GENE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:20 PM EDT
2.30quote price arrow up+0.05 (+2.22%)
Volume
293
Close
2.25quote price arrow down-0.14 (-5.86%)
Volume
27,946
52 week range
1.80 - 5.90
Loading...
  • Open2.42
  • Day High2.46
  • Day Low2.12
  • Prev Close2.39
  • 52 Week High5.90
  • 52 Week High Date05/23/23
  • 52 Week Low1.80
  • 52 Week Low Date02/26/24

Key Stats

  • Market Cap8.656M
  • Shares Out3.85M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.20
  • YTD % Change-6.25

KEY STATS

  • Open2.42
  • Day High2.46
  • Day Low2.12
  • Prev Close2.39
  • 52 Week High5.90
  • 52 Week High Date05/23/23
  • 52 Week Low1.80
  • 52 Week Low Date02/26/24
  • Market Cap8.656M
  • Shares Out3.85M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.20
  • YTD % Change-6.25

RATIOS/PROFITABILITY

  • EPS (TTM)-2.30
  • P/E (TTM)-0.98
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-5.914M
  • ROE (TTM)-160.47%
  • Revenue (TTM)5.506M
  • Gross Margin (TTM)53.55%
  • Net Margin (TTM)-149.69%
  • Debt To Equity (MRQ)7.94%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Genetic Technologies Ltd

 

Profile

MORE
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to...
Peter Rubinstein
Non-Executive Independent Chairman of the Board
Simon Morriss
Chief Executive Officer
Kathryn Andrews
Chief Financial Officer, Company Secretary
Address
60-66 Hanover St, Fitzroy
Melbourne, VIC
3065
Australia